OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 20, 2020
The company’s new closed cell therapy processing system enables scalable, cost-effective development and manufacturing of cell therapies.
April 01, 2020
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
October 08, 2019
Used with perfusion, alternating tangential flow and tangential flow filtration are redefining upstream efficiency.
September 11, 2019
The company’s Custom Single Run product line now has available bioreactors with working volumes of up to 6000 L.
September 03, 2019
The new facility, located in Ness Ziona, Israel, will support clinical phage manufacturing and can be expanded in the future to support commercial-scale manufacturing.
April 15, 2019
The growing trend of partnerships between small biotech companies and CDMOs makes the need for conducting CMC due diligence increasingly important.
Increasingly complex monoclonal antibody molecules will require the right “tool box” for scaling up manufacturing.
April 03, 2019
Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.
March 01, 2019
A look at recent investments by contract manufacturers to increase single-use bioreactor capacity.
January 01, 2019
For rapid scale-up of biomanufacturing under expedited review status, facility design must better integrate product development and manufacturing lifecycle activities.